OptraSCAN is an end-to-end On-Demand Digital Pathology Scanners & Solution Providers for brightfield, frozen sections, fluorescence and confocal applications.
OptraSCAN offers Prostate Cancer Biomarker the leading end-to-end digital pathology solution, provider
The classical Gleason grading system is exclusively based on visual assessment of architectural patterns of prostate adenocarcinoma acknowledged by WHO and further modified and revised in 2004 and 2016 by the International Society of Urological Pathology (ISUP), is a powerful prognostic predictor for patients with prostate carcinoma. However, the histological assessment by pathologists of these tissue slides to evaluate the morphological patterns is often time-consuming and suffers from limited reproducibility. Studies published have reported Intra and Interobserver agreement variability. With the FDA approval for whole slide imaging systems and with rapid technological advances and the advent of computer-aided platforms, the development of machine-based scoring algorithms shows promise in overcoming these challenges and provides a possible approach to accurate, rapid, and reproducible analysis.
Prostate cancer is the most prevalent form of cancer and the second most common cause of death among men in the United States. Automated and deep learning approaches by comparing morphological and quantitative information on digital pathology images have the potential to overcome the above-mentioned limitations to quantitatively characterize the Gleason spectrum and generate reproducible results”, said Anand Maiskar, VP – Sales ROW, OptraScan.
Tel: +1-408-524-5300
Contact us at- info@optrascan.com
Read more about- Affordable Image Slide Scanner
Whole Slide Scanner At No Upfront Cost
OptraSCAN Digital Pathology Scanner and Solution Provider Has Launched On-Demand Digital Pathology SolutionImproving Patient Outcomes With Digital pathology Solutions
Often due to financial constraints or limited internal resources, many lab partners, as well as healthcare providers, face challenges for purchasing the whole slide scanners and scanning of slides. For such challenges, OptraSCAN has come up with a solution – Digital Lab as a Service.Breast Cancer Biomarker Analysis- OptraSCAN Inc
OptraSCAN® is eliminating the barriers to adopting digital pathology no matter the size of the pathology lab, the lab's throughput or location. Our affordable and easy to implement solutions will maximize your return on investment. OptraSCAN will be a partner to help improve the performance of your pathology services.